These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 33745988)

  • 21. Precision Approaches to Chronic Obstructive Pulmonary Disease Management.
    Moll M; Silverman EK
    Annu Rev Med; 2024 Jan; 75():247-262. PubMed ID: 37827193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COPD biomarkers and phenotypes: opportunities for better outcomes with precision imaging.
    Washko GR; Parraga G
    Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30337445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Women manifest more severe COPD symptoms across the life course.
    DeMeo DL; Ramagopalan S; Kavati A; Vegesna A; Han MK; Yadao A; Wilcox TK; Make BJ;
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3021-3029. PubMed ID: 30319250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex Difference in Chronic Obstructive Lung Disease. Does it Matter? A Concise Review.
    Kokturk N; Kilic H; Baha A; Lee SD; Jones PW
    COPD; 2016 Dec; 13(6):799-806. PubMed ID: 27398767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and treatment considerations for women with COPD.
    Cote CG; Chapman KR
    Int J Clin Pract; 2009 Mar; 63(3):486-93. PubMed ID: 19222634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender differences in COPD: are women more susceptible to smoking effects than men?
    Sørheim IC; Johannessen A; Gulsvik A; Bakke PS; Silverman EK; DeMeo DL
    Thorax; 2010 Jun; 65(6):480-5. PubMed ID: 20522842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences Between Men and Women with Chronic Obstructive Pulmonary Disease.
    Jenkins C
    Clin Chest Med; 2021 Sep; 42(3):443-456. PubMed ID: 34353450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study.
    Coxson HO; Dirksen A; Edwards LD; Yates JC; Agusti A; Bakke P; Calverley PM; Celli B; Crim C; Duvoix A; Fauerbach PN; Lomas DA; Macnee W; Mayer RJ; Miller BE; Müller NL; Rennard SI; Silverman EK; Tal-Singer R; Wouters EF; Vestbo J;
    Lancet Respir Med; 2013 Apr; 1(2):129-36. PubMed ID: 24429093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Precision medicine in COPD exacerbations.
    Agusti A; Faner R; Celli B; Rodriguez-Roisin R
    Lancet Respir Med; 2018 Sep; 6(9):657-659. PubMed ID: 30029970
    [No Abstract]   [Full Text] [Related]  

  • 30. Biomarkers for chronic obstructive pulmonary disease diagnosis and progression: insights, disappointments and promise.
    Mannino DM
    Curr Opin Pulm Med; 2019 Mar; 25(2):144-149. PubMed ID: 30520743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic review on recent potential biomarkers of chronic obstructive pulmonary disease.
    Aydindogan E; Penque D; Zoidakis J
    Expert Rev Mol Diagn; 2019 Jan; 19(1):37-45. PubMed ID: 30560707
    [No Abstract]   [Full Text] [Related]  

  • 32. Sex, susceptibility to smoking and chronic obstructive pulmonary disease: the effect of different diagnostic criteria. Analysis of the Health Survey for England.
    Jordan RE; Miller MR; Lam KB; Cheng KK; Marsh J; Adab P
    Thorax; 2012 Jul; 67(7):600-5. PubMed ID: 22382600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic obstructive pulmonary disease: are women more susceptible than men?
    Chapman KR
    Clin Chest Med; 2004 Jun; 25(2):331-41. PubMed ID: 15099893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COPD and gender differences: an update.
    Aryal S; Diaz-Guzman E; Mannino DM
    Transl Res; 2013 Oct; 162(4):208-18. PubMed ID: 23684710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-omics study on biomarker and pathway discovery of chronic obstructive pulmonary disease.
    Tang Y; Chen Z; Fang Z; Zhao J; Zhou Y; Tang C
    J Breath Res; 2021 Sep; 15(4):. PubMed ID: 34280912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Asthma-COPD overlap syndrome and precision medicine.
    Bovornkitti S
    Asian Pac J Allergy Immunol; 2017 Mar; 35(1):1-2. PubMed ID: 28431471
    [No Abstract]   [Full Text] [Related]  

  • 37. Gender differences in plasma biomarker levels in a cohort of COPD patients: a pilot study.
    de Torres JP; Casanova C; Pinto-Plata V; Varo N; Restituto P; Cordoba-Lanus E; Baz-Dávila R; Aguirre-Jaime A; Celli BR
    PLoS One; 2011 Jan; 6(1):e16021. PubMed ID: 21267454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fractional Exhaled Nitric Oxide as an Inflammatory Biomarker in Chronic Obstructive Pulmonary Disease (COPD) with or without Concurrent Diagnosis of Asthma: The Canadian Cohort Obstructive Lung Disease (CanCOLD).
    Mostafavi-Pour-Manshadi SM; Naderi N; Mancino P; Li PZ; Tan W; Bourbeau J
    COPD; 2020 Aug; 17(4):355-365. PubMed ID: 32584165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic obstructive pulmonary disease phenotypes, biomarkers, and prognostic indicators.
    Brightling CE
    Allergy Asthma Proc; 2016 Nov; 37(6):432-438. PubMed ID: 27931297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex Differences in Veterans Admitted to the Hospital for Chronic Obstructive Pulmonary Disease Exacerbation.
    Bade BC; DeRycke EC; Ramsey C; Skanderson M; Crothers K; Haskell S; Bean-Mayberry B; Brandt C; Bastian LA; Akgün KM
    Ann Am Thorac Soc; 2019 Jun; 16(6):707-714. PubMed ID: 30822098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.